Qinglian Wang

324 Jingwu Street
Jinan, 250021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

MEF2A nuclear translocation mediated by ROCK phosphorylation promotes EZH2 expression and peritoneal fibrosis.

MEF2A nuclear translocation mediated by ROCK phosphorylation promotes EZH2 expression and peritoneal fibrosis.

Journal: Renal failure
Published: May 17, 2026

The role of macrophages in peritoneal dialysis-associated peritoneal fibrosis.

The role of macrophages in peritoneal dialysis-associated peritoneal fibrosis.

Journal: Human cell
Published: September 12, 2025

Non-steroidal mineralocorticoid receptor antagonist finerenone inhibits peritoneal fibrosis induced by high-glucose dialysate via regulating enhancer of zeste homolog 2 (EZH2) expression.

Non-steroidal mineralocorticoid receptor antagonist finerenone inhibits peritoneal fibrosis induced by high-glucose dialysate via regulating enhancer of zeste homolog 2 (EZH2) expression.

Journal: Renal failure
Published: May 14, 2025

Finerenone Ameliorates High Glucose-Induced Podocytes Epithelial-Mesenchymal Transition Through the Regulation of Krüppel-Like Factor 5 in Diabetic Nephropathy.

Finerenone Ameliorates High Glucose-Induced Podocytes Epithelial-Mesenchymal Transition Through the Regulation of Krüppel-Like Factor 5 in Diabetic Nephropathy.

Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: October 26, 2024

Network pharmacology, molecular docking, and experimental verification to reveal the mechanism of colquhounia root tablet in the treatment of diabetic nephropathy.

Network pharmacology, molecular docking, and experimental verification to reveal the mechanism of colquhounia root tablet in the treatment of diabetic nephropathy.

Journal: Biochemical and biophysical research communications
Published: September 10, 2024

Dapagliflozin ameliorates high glucose-induced epithelial-mesenchymal transition via up-regulating ACE2 mediated by EZH2 in diabetic nephropathy.

Dapagliflozin ameliorates high glucose-induced epithelial-mesenchymal transition via up-regulating ACE2 mediated by EZH2 in diabetic nephropathy.

Journal: Journal of endocrinological investigation
Published: August 01, 2024

GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathways.

GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathways.

Journal: International immunopharmacology
Published: September 11, 2023

Protective effect of thymol on glycerol-induced acute kidney injury.

Protective effect of thymol on glycerol-induced acute kidney injury.

Journal: Renal failure
Published: July 07, 2023

Dapagliflozin improves podocytes injury in diabetic nephropathy via regulating cholesterol balance through KLF5 targeting the ABCA1 signalling pathway.

Dapagliflozin improves podocytes injury in diabetic nephropathy via regulating cholesterol balance through KLF5 targeting the ABCA1 signalling pathway.

Journal: Diabetology & metabolic syndrome
Published: May 28, 2023

Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho.

Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho.

Journal: Renal failure
Published: February 01, 2023

Histone modification in podocyte injury of diabetic nephropathy.

Histone modification in podocyte injury of diabetic nephropathy.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 26, 2022

Preoperative Cardiac Index as a Predictor of Maturation and Primary Patency of Radiocephalic Arteriovenous Fistula in Hemodialysis.

Preoperative Cardiac Index as a Predictor of Maturation and Primary Patency of Radiocephalic Arteriovenous Fistula in Hemodialysis.

Journal: Blood purification
Published: June 12, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026